Seno receives $2M state investment for breast cancer detection technology
The Texas emerging technology fund (TETF) has awarded the San Antonio, Texas-based Seno Medical Instruments $2 million to develop technology for cancer imaging and detection, and propel its accessibility in the global marketplace.
TETF’s investment was announced at a joint press conference hosted by Phil Wilson, Texas secretary of state, and Janet Campbell, CEO of Seno Medical, at the Cancer Therapy and Research Center in San Antonio.
Created by the Texas legislature in 2005, TETF is a $200 million program, which is controlled by a 17-member advisory committee of high-tech leaders, entrepreneurs and research experts, who review potential TETF projects and recommend funding for designated projects to the governor, lieutenant governor and speaker of the house. To date, TETF has allocated $94.1 million in grants to companies and universities throughout the state.
“By supporting advancing technology projects, such as breast cancer diagnostic devices, we are making a difference in a wide variety of products and services that enhance the quality of lives here today, and in the future,” said Texas Governor Rick Perry.
Seno Medical chose to conduct its initial clinical studies at the Cancer Therapy and Research Center and the University of Texas Health Science Center at San Antonio.
TETF’s investment was announced at a joint press conference hosted by Phil Wilson, Texas secretary of state, and Janet Campbell, CEO of Seno Medical, at the Cancer Therapy and Research Center in San Antonio.
Created by the Texas legislature in 2005, TETF is a $200 million program, which is controlled by a 17-member advisory committee of high-tech leaders, entrepreneurs and research experts, who review potential TETF projects and recommend funding for designated projects to the governor, lieutenant governor and speaker of the house. To date, TETF has allocated $94.1 million in grants to companies and universities throughout the state.
“By supporting advancing technology projects, such as breast cancer diagnostic devices, we are making a difference in a wide variety of products and services that enhance the quality of lives here today, and in the future,” said Texas Governor Rick Perry.
Seno Medical chose to conduct its initial clinical studies at the Cancer Therapy and Research Center and the University of Texas Health Science Center at San Antonio.